COMMUNIQUÉS West-GlobeNewswire

Allscripts Joins with Microsoft to Explore Technology for Clinical Research
07/01/2019
A new operating model to enable research as a natural output of clinical practice, through integration with point-of-care technology platforms and workflows CHICAGO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts ( [...]
Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors
07/01/2019
Anticipates total fourth quarter net sales of $19.0 million, growth of 72% year over year Aesthetic industry veteran Mary M. Fisher joins Sientra’s Board of Directors SANTA BARBARA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE [...]
BioTime Enters Into Exclusive Agreement With Orbit Biomedical Ltd. to Access Innovative Device for the Sub-Retinal Delivery of OpRegen® Cells for the Treatment of Dry-AMD
07/01/2019
ALAMEDA, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it has entered into a [...]
Allakos Announces Positive Phase 2 Results in a Cohort of Xolair-Naïve Chronic Spontaneous Urticaria Patients
07/01/2019
-- 12 of 13 (92%) patients achieved a complete response -- -- Results from 3 additional cohorts expected in the first quarter of 2019 -- REDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ: ALLK [...]
Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue
07/01/2019
Preliminary full year 2018 total revenue of approximately $52.8 million, an increase of approximately 31% over the full year 2017, exceeding previously issued guidance MALVERN, Pa., Jan. 07, 2019 (GLOBE NEWSWIRE) -- [...]
Long-Term Study of 1,000 Tumors Demonstrates Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
07/01/2019
Prospective trial shows that intraoperative radiation therapy (IORT) is a clinically effective, faster and easier alternative to whole breast radiation therapy following breast-conserving surgery for selected low-risk [...]
Aulisa Medical USA, Inc. Enters Market With Wearable, Wireless Continuous Vital Signs Monitoring & Alarm Systems
07/01/2019
Remote Vitals Monitoring Technology for Medical Use PALO ALTO, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Aulisa Medical USA, Inc. today released the first of its Guardian Angel TM Rx line of wireless, wearable [...]
Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference
07/01/2019
CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company that is generating red blood cells and bioengineering them into an entirely new class of cellular [...]
Tabula Rasa HealthCare Completes Acquisition of DoseMe
07/01/2019
MOORESTOWN, N.J., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced that it completed its [...]
Tauriga Sciences, Inc. to Launch an E-Commerce Site to Coincide with the Commercial Launch of its Cannabis/CBD Infused Chewing Gum Product Line
07/01/2019
NEW YORK, NY, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy
07/01/2019
Preparing Three Lead Programs for MLD, ADA-SCID and WAS for Regulatory Filings Over the Next Three Years Recently Announced Clinical Proof-of-Concept in X-CGD Demonstrates Platform’s Transformative Potential Advancing [...]
CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results
07/01/2019
BRISBANE, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Fertin Pharma’s Parent Company Acquires MedCan Pharma - Allowing Entry into Fast-growing Market for Cannabinoid Products
07/01/2019
VEJLE, Denmark, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Claudio Bidco A/S (the “ Parent Company ”), the parent company of Fertin Pharma A/S (“ Fertin Pharma ”) has signed and closed the acquisition of MedCan Pharma A/S (“ [...]
Nuvectra® Announces Preliminary Unaudited Fourth Quarter and Full Year 2018 Revenue
07/01/2019
PLANO, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary unaudited revenue for the fourth quarter and full year ended [...]
Tecan to present at J.P. Morgan Healthcare Conference
07/01/2019
Männedorf, Switzerland, January 7, 2019 - The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at J.P. Morgan Healthcare Conference in San Francisco, USA, on January 10, 2019. The investor [...]
Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company
07/01/2019
– Transaction Expected to Create NASDAQ-listed Biopharmaceutical Company Focused on Advancing Immunic‘s Compelling Pipeline of Clinical-Stage and Late Preclinical Assets – – Lead Program, IMU-838, an Orally Available, [...]
FIT Biotech Oy: Changes in FIT Biotech's Board of Directors
07/01/2019
FIT Biotech Oy Company release 7.1.2019 at 9:55 EET Changes in FIT Biotech's Board of Directors FIT Biotech Oy's ("Company", FITBIO: FN Finland) Chairman of the Board of Directors, Doctor Chitra Bharucha has resigned [...]
Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
07/01/2019
Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs Companies select two clinical-stage bispecific antibodies for ongoing collaboration Sanofi able to independently [...]
Sanofi et Regeneron restructurent leur collaboration de recherche et développement en immuno-oncologie
07/01/2019
Sanofi et Regeneron restructurent leur collaboration de recherche et développement en immuno-oncologie Les deux entreprises retiennent deux anticorps bispécifiques au stade clinique pour la poursuite de leur [...]

Pages